To include your compound in the COVID-19 Resource Center, submit it here.

Nov. 1 Financial Quick Takes: Kira raises $13.8M series A; plus SinoMab, Tot, Shasqi and Sense Biodetection

Autoimmune play Kira launches with $13.8M series A
Kira Biotech raised A$20 million ($13.8 million) in a series A round led by OneVentures, IP Group and the Advance Queensland Business

Read the full 297 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury


Article Purchase

This article may not be distributed to non-subscribers